We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NVAX market cap is 557.01M. The company's latest EPS is USD -3.8946 and P/E is -1.02.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 734.58M | 357.4M | 80.95M | 424.43M | 186.99M |
Operating Income | -127.19M | -243.88M | -312.77M | 55.46M | -125.63M |
Net Income | -168.61M | -182.25M | -293.91M | 58.01M | -130.78M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 18.66M | 475.6M | 1.15B | 1.98B | 983.71M |
Operating Income | -129.6M | -416.72M | -1.69B | -644.74M | -566.51M |
Net Income | -132.69M | -418.26M | -1.74B | -657.94M | -545.06M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 2.27B | 2.26B | 1.54B | 1.69B | 1.66B |
Total Liabilities | 2.83B | 2.89B | 2.44B | 2.44B | 2.34B |
Total Equity | -565.99M | -634.08M | -895.58M | -754.52M | -678.35M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 172.96M | 1.58B | 2.58B | 2.26B | 1.8B |
Total Liabilities | 358.97M | 955.27M | 2.93B | 2.89B | 2.51B |
Total Equity | -186.02M | 627.21M | -351.67M | -634.08M | -716.93M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -298.12M | -415.94M | -325.59M | -497.53M | -537.19M |
Investing | -70.92M | -92.99M | -23.56M | -31.34M | -49.73M |
Financing | 133.55M | 324.99M | -354.38M | -293.04M | -95.92M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -136.62M | -42.54M | 322.95M | -415.94M | -713.97M |
Investing | 38.49M | -377.78M | 100.15M | -92.99M | -58.81M |
Financing | 98.38M | 984.76M | 461.71M | 324.99M | 4.47M |
Market Cap | 557.01M |
Price to Earnings Ratio | -1.02 |
Price to Sales Ratio | 0.57 |
Price to Cash Ratio | 0.98 |
Price to Book Ratio | -0.78 |
Dividend Yield | - |
Shares Outstanding | 139.95M |
Average Volume (1 week) | 3.86M |
Average Volume (1 Month) | 3.78M |
52 Week Change | -56.26% |
52 Week High | 11.36 |
52 Week Low | 3.5324 |
Spread (Intraday) | 0.12 (3.02%) |
Company Name | Novavax Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.novavax.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions